异位培养和诱导T淋巴细胞的胸腺类器官的发育

IF 2.7 4区 医学 Q3 IMMUNOLOGY
Xiuxia Wang, Shun Yu, Yucheng Qiu, Jun Yang, Fei Liu, Xianyu Zhou
{"title":"异位培养和诱导T淋巴细胞的胸腺类器官的发育","authors":"Xiuxia Wang,&nbsp;Shun Yu,&nbsp;Yucheng Qiu,&nbsp;Jun Yang,&nbsp;Fei Liu,&nbsp;Xianyu Zhou","doi":"10.1002/iid3.70229","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Vascularized composite allotransplantation (VCA) is a potential treatment for extensive injuries that replaces defects like-with-like, however allografts are immune-rejectable.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This study developed in vitro thymic organoids and examined whether donor-derived HSCs could be educated in vivo into T lymphocytes via central tolerance. TECs, TMCs, and HSCs from C57BL/7 (CD45.2<sup>+</sup>) or SJL/L (CD45.1<sup>+</sup>) mice were labeled with cell surface markers and examined by flow cytometry. Co-culturing three cell lines in vitro created thymic aggregates. Aggregates transplanted to C57BL/7 (CD45.2<sup>+</sup>) mice′s inguinal regions developed thymic organoids. Immunorejection genes were identified bioinformatically. Western blot, immunofluorescence, and flow cytometry were utilized to measure rejection-related protein levels and T cell surface markers in thymic organoids to determine T cell inducement and immunomodulation.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In vitro, TECs, TMCs, and HSCs created thymic aggregates, which became thymic organoids after in vivo transplantation and produced CD8<sup>+</sup> and CD4<sup>+</sup> Tregs. Bioinformatics showed high correlations between transplanted rejection and IFNG, IL2RG, FCGR3A, and ICAM1 genes. Immunofluorescence and Western blot showed increased protein expression of IFNG, IL2RG, FCGR3A (immunomodulation biomarker), and decreased protein expression of CK8, CK14, and ICAM1 (TEC biomarker) in thymic organoids.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Thymic organoids heterotopically implanted in vivo can promote heterologous HSC-derived T cell development.</p>\n </section>\n </div>","PeriodicalId":13289,"journal":{"name":"Immunity, Inflammation and Disease","volume":"13 8","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iid3.70229","citationCount":"0","resultStr":"{\"title\":\"Development of Thymic Organoids Heterotopically to Educate and Induce T Lymphocytes\",\"authors\":\"Xiuxia Wang,&nbsp;Shun Yu,&nbsp;Yucheng Qiu,&nbsp;Jun Yang,&nbsp;Fei Liu,&nbsp;Xianyu Zhou\",\"doi\":\"10.1002/iid3.70229\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Vascularized composite allotransplantation (VCA) is a potential treatment for extensive injuries that replaces defects like-with-like, however allografts are immune-rejectable.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>This study developed in vitro thymic organoids and examined whether donor-derived HSCs could be educated in vivo into T lymphocytes via central tolerance. TECs, TMCs, and HSCs from C57BL/7 (CD45.2<sup>+</sup>) or SJL/L (CD45.1<sup>+</sup>) mice were labeled with cell surface markers and examined by flow cytometry. Co-culturing three cell lines in vitro created thymic aggregates. Aggregates transplanted to C57BL/7 (CD45.2<sup>+</sup>) mice′s inguinal regions developed thymic organoids. Immunorejection genes were identified bioinformatically. Western blot, immunofluorescence, and flow cytometry were utilized to measure rejection-related protein levels and T cell surface markers in thymic organoids to determine T cell inducement and immunomodulation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>In vitro, TECs, TMCs, and HSCs created thymic aggregates, which became thymic organoids after in vivo transplantation and produced CD8<sup>+</sup> and CD4<sup>+</sup> Tregs. Bioinformatics showed high correlations between transplanted rejection and IFNG, IL2RG, FCGR3A, and ICAM1 genes. Immunofluorescence and Western blot showed increased protein expression of IFNG, IL2RG, FCGR3A (immunomodulation biomarker), and decreased protein expression of CK8, CK14, and ICAM1 (TEC biomarker) in thymic organoids.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Thymic organoids heterotopically implanted in vivo can promote heterologous HSC-derived T cell development.</p>\\n </section>\\n </div>\",\"PeriodicalId\":13289,\"journal\":{\"name\":\"Immunity, Inflammation and Disease\",\"volume\":\"13 8\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iid3.70229\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunity, Inflammation and Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/iid3.70229\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity, Inflammation and Disease","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/iid3.70229","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

血管化复合同种异体移植(VCA)是一种潜在的治疗大面积损伤的方法,可以替代同种异体的缺陷,然而同种异体移植物具有免疫排斥性。方法体外培养胸腺类器官,观察供体来源的造血干细胞能否通过中枢耐受进入T淋巴细胞。用细胞表面标志物对C57BL/7 (CD45.2+)或SJL/L (CD45.1+)小鼠的tec、tmc和hsc进行标记,并用流式细胞术检测。三种细胞系体外共培养可产生胸腺聚集体。聚集体移植到C57BL/7 (CD45.2+)小鼠腹股沟区域形成胸腺类器官。用生物信息学方法鉴定免疫排斥基因。采用Western blot、免疫荧光和流式细胞术检测胸腺类器官中排斥相关蛋白水平和T细胞表面标记物,以确定T细胞诱导和免疫调节作用。结果体外培养的TECs、TMCs和hsc均产生胸腺聚集体,在体内移植后成为胸腺类器官,并产生CD8+和CD4+ treg。生物信息学显示移植排斥反应与IFNG、IL2RG、FCGR3A和ICAM1基因高度相关。免疫荧光和Western blot显示,胸腺类器官中IFNG、IL2RG、FCGR3A(免疫调节生物标志物)的蛋白表达增加,CK8、CK14、ICAM1 (TEC生物标志物)的蛋白表达降低。结论胸腺类器官体内异体移植可促进异体造血干细胞来源的T细胞发育。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Development of Thymic Organoids Heterotopically to Educate and Induce T Lymphocytes

Development of Thymic Organoids Heterotopically to Educate and Induce T Lymphocytes

Background

Vascularized composite allotransplantation (VCA) is a potential treatment for extensive injuries that replaces defects like-with-like, however allografts are immune-rejectable.

Methods

This study developed in vitro thymic organoids and examined whether donor-derived HSCs could be educated in vivo into T lymphocytes via central tolerance. TECs, TMCs, and HSCs from C57BL/7 (CD45.2+) or SJL/L (CD45.1+) mice were labeled with cell surface markers and examined by flow cytometry. Co-culturing three cell lines in vitro created thymic aggregates. Aggregates transplanted to C57BL/7 (CD45.2+) mice′s inguinal regions developed thymic organoids. Immunorejection genes were identified bioinformatically. Western blot, immunofluorescence, and flow cytometry were utilized to measure rejection-related protein levels and T cell surface markers in thymic organoids to determine T cell inducement and immunomodulation.

Results

In vitro, TECs, TMCs, and HSCs created thymic aggregates, which became thymic organoids after in vivo transplantation and produced CD8+ and CD4+ Tregs. Bioinformatics showed high correlations between transplanted rejection and IFNG, IL2RG, FCGR3A, and ICAM1 genes. Immunofluorescence and Western blot showed increased protein expression of IFNG, IL2RG, FCGR3A (immunomodulation biomarker), and decreased protein expression of CK8, CK14, and ICAM1 (TEC biomarker) in thymic organoids.

Conclusion

Thymic organoids heterotopically implanted in vivo can promote heterologous HSC-derived T cell development.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease Medicine-Immunology and Allergy
CiteScore
3.60
自引率
0.00%
发文量
146
审稿时长
8 weeks
期刊介绍: Immunity, Inflammation and Disease is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research across the broad field of immunology. Immunity, Inflammation and Disease gives rapid consideration to papers in all areas of clinical and basic research. The journal is indexed in Medline and the Science Citation Index Expanded (part of Web of Science), among others. It welcomes original work that enhances the understanding of immunology in areas including: • cellular and molecular immunology • clinical immunology • allergy • immunochemistry • immunogenetics • immune signalling • immune development • imaging • mathematical modelling • autoimmunity • transplantation immunology • cancer immunology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信